SCYNEXIS (SCYX) Received its Third Buy in a Row

After Needham and H.C. Wainwright gave SCYNEXIS (NASDAQ: SCYX) a Buy rating last month, the company received another Buy, this time from WBB Securities. Analyst Stephen Brozak reiterated a Buy rating on More »

AzurRx BioPharma Inc (AZRX) Received its Third Buy in a Row

After Oppenheimer and Maxim Group gave AzurRx BioPharma Inc (NASDAQ: AZRX) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Ram Selvaraju reiterated a Buy More »